FIELD: pharmaceutics.
SUBSTANCE: invention relates to pharmaceutics, namely to dosage form in form of tablets with tensile strength of at least 500 N containing pharmacologically active component (A) selected from hydrocodone, hydromorphone, morphine, oxycodone, oxymorphone, tramadol and their pharmaceutically acceptable salts; polymer (B) selected from (i) homopolymer of acrylic acid, cross-linked allyl sucrose or allyl pentaerythritol, or (ii) copolymer of acrylic acid and C10-C30-alkyl-acrylate, cross-linked allyl pentaerythritol, or (iii) interpolymer selected from homopolymers of acrylic acid, cross-linked allyl sucrose or allyl pentaerythritol, and copolymers of acrylic acid and C10-C30-alkyl-acrylate, cross-linked allyl pentaerythritol containing copolymer block of polyethylene glycol and ester of C8-C30-alkyl acid; and from 30 to 90 wt% of polyethylene oxide (C) with average molecular weight from 2,500,000 to 15,000,000 g/mol, wherein component (A) is present in controlled-release matrix containing polymer (B) and polyethylene oxide (C).
EFFECT: invention provides production of destruction-resistant dosage forms with prolonged release of active component.
5 cl, 8 ex, 19 tbl, 16 dwg
Title | Year | Author | Number |
---|---|---|---|
DESTRUCTION-RESISTANT DOSAGE FORM CONTAINING AN INORGANIC SALT | 2011 |
|
RU2604676C2 |
OXIDATION STABLE AND BREAKING RESISTANCE DOSAGE FORM | 2010 |
|
RU2567723C2 |
PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2589842C2 |
DRUG FORM | 2009 |
|
RU2493830C2 |
MISUSE PROTECTED DOSAGE FORM FOR OXIDATION SENSITIVE OPIOIDS | 2010 |
|
RU2555531C2 |
LAYERS FOR MECHANICAL PROTECTION OF SOLID DOSAGE FORMS | 2008 |
|
RU2500389C2 |
PHARMACEUTICAL COMPOSITION OF OMEPRAZOL | 2012 |
|
RU2647472C2 |
PERORAL DABIGATRAN ETEXILATE PHARMACEUTICAL COMPOSITIONS | 2013 |
|
RU2633482C2 |
PHARMACEUTICAL COMPOSITIONS OF ACOTIAMIDE AND PROTON PUMP INHIBITOR | 2019 |
|
RU2820820C2 |
PHARMACEUTICAL COMPOSITION CONTAINING BENZOCAINE WITH ENHANCED STABILITY | 2018 |
|
RU2761828C2 |
Authors
Dates
2017-01-10—Published
2011-09-01—Filed